These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17015777)

  • 1. Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension.
    Opocenský M; Kramer HJ; Bäcker A; Vernerová Z; Eis V; Cervenka L; Certíková Chábová V; Tesar V; Vanecková I
    Hypertension; 2006 Nov; 48(5):965-71. PubMed ID: 17015777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P; Kramer HJ; Bäcker A; Malý J; Kopkan L; Vanecková I; Vernerová Z; Opocenský M; Tesar V; Bader M; Ganten D; Janda J; Cervenka L
    Kidney Blood Press Res; 2004; 27(4):248-58. PubMed ID: 15286437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade.
    Vernerová Z; Kujal P; Kramer HJ; Bäcker A; Cervenka L; Vaneckova I
    Physiol Res; 2009; 58 Suppl 2():S69-S78. PubMed ID: 20131938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats.
    Vanêcková I; Kramer HJ; Bäcker A; Vernerová Z; Opocensky M; Cervenka L
    Hypertension; 2005 Oct; 46(4):969-74. PubMed ID: 16157796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats.
    Vernerová Z; Kramer HJ; Bäcker A; Cervenka L; Opocenský M; Husková Z; Vanourková Z; Eis V; Chábová VC; Tesar V; Malý J; Vanecková I
    Vascul Pharmacol; 2008; 48(4-6):165-73. PubMed ID: 18372220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats.
    Vanecková I; Kramer HJ; Bäcker A; Schejbalová S; Vernerová Z; Eis V; Opocenský M; Dvorák P; Cervenka L
    Vascul Pharmacol; 2006 Sep; 45(3):163-70. PubMed ID: 16807127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
    Opocenský M; Dvorák P; Malý J; Kramer HJ; Bäcker A; Kopkan L; Vernerová Z; Tesar V; Zima T; Bader M; Ganten D; Janda J; Vanecková I
    Physiol Res; 2004; 53(6):581-93. PubMed ID: 15588125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin A receptor blocker atrasentan lowers blood pressure by the reduction of nifedipine-sensitive calcium influx in Ren-2 transgenic rats fed a high-salt diet.
    Vaněčková I; Dobešová Z; Kuneš J; Vernerová Z; Zicha J
    J Hypertens; 2015 Jan; 33(1):161-9. PubMed ID: 25255392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension.
    Vanourková Z; Kramer HJ; Erbanová M; Bäcker A; Cervenka L; Husková Z; Chábová VC; Tesar V; Dvorák P; Malý J; Vanecková I
    Vascul Pharmacol; 2009; 50(5-6):194-9. PubMed ID: 19563737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
    Rothermund L; Kossmehl P; Neumayer HH; Paul M; Kreutz R
    J Hypertens; 2003 Dec; 21(12):2389-97. PubMed ID: 14654760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
    Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
    Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
    Circulation; 2005 Jan; 111(3):302-9. PubMed ID: 15642760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct effects of bosentan on NO-dependent vasodilation and calcium influx in heterozygous Ren-2 transgenic rats on high-salt diet.
    Vaněčková I; Hojná S; Kadlecová M; Kompanowska-Jezierska E; Zicha J
    Physiol Res; 2019 Oct; 68(5):717-725. PubMed ID: 31424254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
    Čertíková Chábová V; Vernerová Z; Kujal P; Husková Z; Škaroupková P; Tesař V; Kramer HJ; Kompanowska-Jezierska E; Walkowska A; Sadowski J; Červenka L; Vaněčková I
    Life Sci; 2014 Nov; 118(2):297-305. PubMed ID: 24373834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
    Lee TM; Chen CC; Lin MS; Chang NC
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling.
    El-Mas MM; Helmy MW; Ali RM; El-Gowelli HM
    Toxicol Appl Pharmacol; 2015 Apr; 284(1):1-7. PubMed ID: 25656942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphological characteristic of renal injury in hypertensive rat strain transgenic for the mouse Ren-2 renin gene (TGR [mRen2] 27].
    Vernerová Z
    Cesk Fysiol; 2007; 56(2):79-84. PubMed ID: 17691484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of systemic and renal intramedullary endothelin-1 receptor blockade on tissue NO and intrarenal hemodynamics in normotensive and hypertensive rats.
    Bądzyńska B; Vaneckova I; Sadowski J; Hojná S; Kompanowska-Jezierska E
    Eur J Pharmacol; 2021 Nov; 910():174445. PubMed ID: 34492284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats.
    Kassab S; Miller MT; Novak J; Reckelhoff J; Clower B; Granger JP
    Hypertension; 1998 Jan; 31(1 Pt 2):397-402. PubMed ID: 9453335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease.
    Saleh MA; Pollock JS; Pollock DM
    J Pharmacol Exp Ther; 2011 Jul; 338(1):263-70. PubMed ID: 21471190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.